Sugi Predict

Sugi Predict / Compounds / SCHEMBL1853729

SCHEMBL1853729

SCHEMBL1853729

[CH2]c1nccc2[nH]ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 2/20 0.45
▸ PRKCI P41743 3/20 0.39
▸ AXL P30530 1/20 0.39
▸ PIK3CD O00329 1/20 0.39
▸ DRD1 P21728 7/20 0.39
▸ AHR P35869 1/20 0.38
▸ IGF1R P08069 2/20 0.35
▸ DYRK1B Q9Y463 2/20 0.35
▸ IKBKB O14920 1/20 0.35
▸ CHUK O15111 1/20 0.35
▸ DAPK3 O43293 1/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ PRKD3 O94806 1/20 0.35
▸ MAP4K4 O95819 1/20 0.35
▸ PAK4 O96013 1/20 0.35
▸ CSF1R P07333 1/20 0.35
▸ RET P07949 1/20 0.35
▸ FGFR1 P11362 1/20 0.35
▸ PRKACA P17612 1/20 0.35
▸ FLT1 P17948 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL399329 0.74 TRPA1 (0.45) TRPA1PRKCIAXLPIK3CDDRD1
SCHEMBL961508 0.74 PRKCI (0.48) TRPA1PRKCIAXLPIK3CDDRD1
SCHEMBL4550230 0.74 PDE3B (0.58) TRPA1PRKCIAXLPIK3CDDRD1
SCHEMBL1019530 0.74 PDE3B (0.53) TRPA1PRKCIAXLPIK3CDDRD1
SCHEMBL1154939 0.74 TRPA1 (0.45) TRPA1PRKCIAXLPIK3CDDRD1
Hydrochloric Acid SCHEMBL5088055 0.72 TRPA1 (0.44) TRPA1PRKCIAXLPIK3CDDRD1
SCHEMBL1176829 0.70 PRKCI (0.59) PRKCIAXLIGF1RDYRK1BIKBKB
SCHEMBL23877021 0.69 TRPA1 (0.45) TRPA1PRKCIAXLPIK3CDDRD1
SCHEMBL15058190 0.69 TRPA1 (0.41) TRPA1PRKCIAXLPIK3CDDRD1
SCHEMBL143655 0.69 DRD1 (0.43) TRPA1PRKCIAXLPIK3CDDRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8242116-B2 Fused thiazole derivatives as kinase inhibitors UCB PHARMA S.A. (BE) 2012-08-14 — — US disclosed
EP-2035436-B1 FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2011-05-25 — — EP disclosed
US-20100137302-A1 Fused Thiazole Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-06-03 — — US disclosed
WO-2009122148-A1 FUSED THIOPHENE AND THIAZOLE DERIVATIVES AS PI3K KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-10-08 — — WO disclosed
WO-2009071888-A1 PYRROLOTHIAZOLES AS PI3-KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-06-11 — — WO disclosed
WO-2009071890-A1 TRICYCLIC KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-06-11 — — WO disclosed
WO-2009071895-A1 FUSED THIAZOLE AND THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-06-11 — — WO disclosed
EP-2035436-A1 FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS UCB Pharma S.A. (BE) 2009-03-18 — — EP disclosed
WO-2008001076-A1 FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2008-01-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137302-A1 Fused Thiazole Derivatives as Kinase Inhibitors PI4KA, PDPK1, PIK3CA TRPA1 259/4885PRKCI 415/4885AXL 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.